aldosterone has been researched along with Carditis in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, tempol failed to suppress cardiac hypertrophy, the formation of inflammatory lesions, and upregulation of cardiac MCP-1 and osteopontin by aldosterone, while N-acetylcysteine could inhibit all of them." | 5.33 | Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress. ( Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Ueda, M; Wake, R; Yoshida, K; Yoshiyama, M; Yukimura, T, 2005) |
| "However, tempol failed to suppress cardiac hypertrophy, the formation of inflammatory lesions, and upregulation of cardiac MCP-1 and osteopontin by aldosterone, while N-acetylcysteine could inhibit all of them." | 1.33 | Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress. ( Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Ueda, M; Wake, R; Yoshida, K; Yoshiyama, M; Yukimura, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardona, A | 1 |
| Baker, P | 1 |
| Kahwash, R | 1 |
| Smart, S | 1 |
| Phay, JE | 1 |
| Basso, C | 1 |
| Raman, SV | 1 |
| Heier, CR | 1 |
| Yu, Q | 1 |
| Fiorillo, AA | 1 |
| Tully, CB | 1 |
| Tucker, A | 1 |
| Mazala, DA | 1 |
| Uaesoontrachoon, K | 1 |
| Srinivassane, S | 1 |
| Damsker, JM | 1 |
| Hoffman, EP | 1 |
| Nagaraju, K | 1 |
| Spurney, CF | 1 |
| Yasuoka, S | 1 |
| Kai, H | 1 |
| Kajimoto, H | 1 |
| Kudo, H | 1 |
| Takayama, N | 1 |
| Anegawa, T | 1 |
| Koga, M | 1 |
| Miyamoto, T | 1 |
| Mifune, H | 1 |
| Kage, M | 1 |
| Hirooka, Y | 1 |
| Imaizumi, T | 1 |
| Hattori, T | 1 |
| Murase, T | 1 |
| Sugiura, Y | 1 |
| Nagasawa, K | 1 |
| Takahashi, K | 1 |
| Ohtake, M | 2 |
| Miyachi, M | 1 |
| Murohara, T | 1 |
| Nagata, K | 1 |
| Rickard, AJ | 1 |
| Morgan, J | 1 |
| Chrissobolis, S | 1 |
| Miller, AA | 1 |
| Sobey, CG | 1 |
| Young, MJ | 1 |
| Westcott, KV | 1 |
| Huang, BS | 1 |
| Leenen, FH | 1 |
| SANDERS, LL | 1 |
| MELBY, JC | 1 |
| Yoshida, K | 1 |
| Kim-Mitsuyama, S | 1 |
| Wake, R | 1 |
| Izumiya, Y | 1 |
| Izumi, Y | 1 |
| Yukimura, T | 1 |
| Ueda, M | 1 |
| Yoshiyama, M | 1 |
| Iwao, H | 1 |
| Neves, MF | 1 |
| Amiri, F | 1 |
| Virdis, A | 1 |
| Diep, QN | 1 |
| Schiffrin, EL | 1 |
| Fraccarollo, D | 1 |
| Galuppo, P | 1 |
| Schraut, S | 1 |
| Kneitz, S | 1 |
| van Rooijen, N | 1 |
| Ertl, G | 1 |
| Bauersachs, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Open-Label, Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)[NCT05185622] | Phase 2 | 54 participants (Anticipated) | Interventional | 2022-03-21 | Recruiting | ||
| A Phase II Pilot Trial of Vamorolone vs. Placebo for the Treatment of Becker Muscular Dystrophy[NCT05166109] | Phase 2 | 39 participants (Anticipated) | Interventional | 2022-07-07 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for aldosterone and Carditis
| Article | Year |
|---|---|
Brain renin-angiotensin-aldosterone system and ventricular remodeling after myocardial infarct: a review.
Topics: Aldosterone; Animals; Apoptosis; Brain; Humans; Myocardial Infarction; Myocarditis; Myocytes, Cardia | 2009 |
9 other studies available for aldosterone and Carditis
| Article | Year |
|---|---|
Evidence of aldosterone synthesis in human myocardium in acute myocarditis.
Topics: Acute Disease; Adult; Aldosterone; Biomarkers; Biopsy; Female; Humans; Immunohistochemistry; Male; M | 2019 |
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Cardiomyopathies; Computer Simulation; CRISPR-Associ | 2019 |
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Cardiomyopathies; Computer Simulation; CRISPR-Associ | 2019 |
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Cardiomyopathies; Computer Simulation; CRISPR-Associ | 2019 |
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Cardiomyopathies; Computer Simulation; CRISPR-Associ | 2019 |
Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats.
Topics: Active Transport, Cell Nucleus; Aldosterone; Animals; Blood Pressure; Cardiomegaly; Cell Nucleus; Ep | 2013 |
Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Echocardiography; Endoth | 2014 |
Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure.
Topics: Aldosterone; Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Cells, Cultured; Conne | 2014 |
ALDOSTERONE AND THE EDEMA OF CONGESTIVE HEART FAILURE.
Topics: Aldosterone; Chromatography; Diuretics; Edema; Geriatrics; Heart Diseases; Heart Failure; Hypertensi | 1964 |
Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress.
Topics: Acetylcysteine; Aldosterone; Animals; Blood Pressure; Cardiomegaly; Chemokine CCL2; Echocardiography | 2005 |
Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Topics: Aldosterone; Angiotensin II; Animals; Aorta; Collagen; Ectodysplasins; Fibrosis; Heart; Hypertension | 2005 |
Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response.
Topics: Aldosterone; Animals; Clodronic Acid; Collagen; Cytokines; Eplerenone; Factor XIIIa; Heart Failure; | 2008 |